Anchorage, AK4 Active Studies

Endometrial Cancer Clinical Trials in Anchorage, AK

Find 4 actively recruiting endometrial cancer clinical trials in Anchorage, AK. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
1,182
Enrolling

Recruiting Endometrial Cancer Studies in Anchorage

RecruitingAnchorage, AKNCT05640999

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

This protocol tests de-escalated adjuvant treatment in patients with POLE-mutated or p53wt/NSMP (p53 wildtype/no specific molecular profile) early-stage endometrial cancer (EC). Patients may be enroll...

393 participants
Canadian Cancer Trials Group
View Study Details
RecruitingAnchorage, AKNCT05256225

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

This phase III trial tests whether adding trastuzumab and hyaluronidase-oysk (Herceptin Hylecta \[TM\]) or pertuzumab, trastuzumab and hyaluronidase-zzxf (Phesgo \[TM\]) to the usual chemotherapy (pac...

360 participants
National Cancer Institute (NCI)
View Study Details
RecruitingAnchorage, AKNCT05548296

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

This is an open label Phase 2 study to evaluate the efficacy and safety of ACR-368 as monotherapy or with ultra-low dose gemcitabine (ULDG) sensitization in participants with endometrial cancer....

353 participants
Acrivon Therapeutics
View Study Details
RecruitingAnchorage, AKNCT04814108

A Study of ZN-c3 in Women With Recurrent or Persistent Uterine Serous Carcinoma

This is a Phase 2 study to evaluate the clinical activity and safety of ZN-c3 (azenosertib) in adult women with recurrent or persistent uterine serous carcinoma (USC)....

76 participants
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
View Study Details

About Endometrial Cancer Clinical Trials in Anchorage

Endometrial cancer begins in the lining of the uterus and is the most common gynecologic cancer. It is often detected early due to abnormal bleeding symptoms. Treatment typically involves surgery, with radiation, chemotherapy, or hormone therapy for advanced cases.

There are currently 4 endometrial cancer clinical trials recruiting participants in Anchorage, AK. These studies are seeking a combined 1,182 participants. Research is being sponsored by Canadian Cancer Trials Group, National Cancer Institute (NCI), Acrivon Therapeutics and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Endometrial Cancer Clinical Trials in Anchorage — FAQ

Are there endometrial cancer clinical trials in Anchorage?

Yes, there are 4 endometrial cancer clinical trials currently recruiting in Anchorage, AK. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Anchorage?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Anchorage research site will contact you about next steps.

Are clinical trials in Anchorage free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Anchorage studies also compensate for your time and travel.

What endometrial cancer treatments are being tested?

The 4 active trials in Anchorage are testing new therapies including novel drugs, biologics, and treatment approaches for endometrial cancer.

Data updated March 2, 2026 from ClinicalTrials.gov